{
    "id": "a6e52787-dbcc-4bd0-8fa1-6875b3e80e2a",
    "indications": "SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).",
    "contraindications": "The recommended dose for SYFOVRE is 15 mg (0.1 mL of 150 mg/mL solution) administered by intravitreal injection to each affected eye once every 25 to 60 days. ( 2.2 )",
    "adverseReactions": "Ocular or Periocular Infections ( 4.1 ) Active Intraocular Inflammation ( 4.2 ) Hypersensitivity ( 4.3 )",
    "ingredients": [
        {
            "name": "Pegcetacoplan",
            "code": "TO3JYR3BOU"
        },
        {
            "name": "Trehalose dihydrate",
            "code": "7YIN7J07X4"
        },
        {
            "name": "ACETIC ACID",
            "code": "Q40Q9N063P"
        },
        {
            "name": "SODIUM ACETATE",
            "code": "4550K0SC9B"
        },
        {
            "name": "Sodium Hydroxide",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "organization": "Apellis Pharmaceuticals, Inc.",
    "name": "Syfovre",
    "effectiveTime": "20250506"
}